Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hcl
NDC Package 70692-133-82

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hcl is temporarily relieves these common cold and flu symptoms: *headache *cough *minor aches and pains *sore throat *sinus congestion and pressuretempoararily reduces feverhelps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-133 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
70692-133-82
Package Description
8 TABLET, COATED in 1 PACKAGE
Product Code
70692-133
11-Digit Billing Format
70692013382
RxNorm Crosswalk
  • RxCUI: 1110988 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1110988 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1110988 - APAP 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hcl
Dosage Form
-
Usage Information
Temporarily relieves these common cold and flu symptoms: *headache *cough *minor aches and pains *sore throat *sinus congestion and pressuretempoararily reduces feverhelps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
07-10-2019
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-133-82 identifies a specific commercial package of 8 tablet, coated in 1 package of Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hcl, labeled by Strive Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strive Pharmaceuticals Inc. on July 10, 2019. The current certification is valid through December 31, 2021.

How is this Strive Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692013382. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-133-82
11-Digit CMS (5-4-2)
70692-0133-82

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.